Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Not yet recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=ritonavir&type0%5B%5D=AllFields&op0%5B%5D=OR&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Not+yet+recruiting%22
PubPharm (915)
1
Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis : Open Label Phase 2 Clinical Study of Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19 : Evaluation of the Safety and Efficacy of Azvudine and Paxlovid in the Treatment of Hospitalized Patients With COVID-19
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis : Open Label Phase 2 Clinical Study of Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain. : A Retrospective Observational Non-Interventional Study (NIS) to Assess Patient Characteristics and Healthcare Resource Use (HRU) Among COVID-19 Patients With or Without Nirmatrelvir/Ritonavir (PAXLOVID™) Treatment in the Kingdom of Bahrain.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco : A Retrospective Observational Non-Interventional Study (NIS) to Assess Patient Characteristics Among COVID-19 Patients Receiving Treatment With Nirmatrelvir/Ritonavir (PAXLOVIDTM) in Morocco.
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
6
Switch to MK-1439A from Ritonavir-boosted Protease Inhibitor regimen in HIV-1 infected subjects : A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs).SUBTITLE: Amendment to Include Switches From Additional Antiretroviral Regimens. - Switch to MK-1439A from PI, EVG- or NNRTI-based regimen for HIV-1 infection
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Switch to MK-1439A from Ritonavir-boosted Protease Inhibitor regimen in HIV-1 infected subjects : A Phase III Multicenter, Open-Label, Randomized Study to Evaluate a Switch to MK-1439A in HIV-1-Infected Subjects Virologically Suppressed on a Regimen of a Ritonavir-boosted Protease Inhibitor and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs).SUBTITLE: Amendment to Include Switches From Additional Antiretroviral Regimens. - Switch to MK-1439A from PI, EVG- or NNRTI-based regimen for HIV-1 infection
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Plasma concentration determination and pharmacokinetics study of Nirmatrelvir/Ritonavir tablets in children : Plasma concentration determination and pharmacokinetics study of Nirmatrelvir/Ritonavir tablets in children
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Plasma concentration determination and pharmacokinetics study of Nirmatrelvir/Ritonavir tablets in children : Plasma concentration determination and pharmacokinetics study of Nirmatrelvir/Ritonavir tablets in children
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation (LOLIPOP) : Phase I/II, open label, randomized crossover pharmacokinetic, safety and acceptability study of the Abacavir/Lamivudine/ Lopinavir/Ritonavir/ - 30/15/ 40/10mg (4-in-1) Fixed-Dose Combination vs. Lopinavir/Ritonavir- 40/10mg pellets plus dual Abacavir/Lamivudine- 60/30mg tablets in HIV infected Children
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[92]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Not yet recruiting
Medienart
915
Aufsätze
915
E-Artikel
915
E-Ressourcen
Zeitschriftentitel
898
WHO International Clinical Trials Registry Plat...
17
ClinicalTrials.gov
Thema
915
610
Recruitment Status: Not yet recruiting
898
Study Type: Interventional
199
Phase: Phase 3
89
Phase: Phase 2
89
Phase: Phase 4
48
Medical Condition: Chronic Hepatitis C Infectio...
20
Medical Condition: HIV-1 MedDRA version: 9.1Lev...
18
Medical Condition: Treatment of HIV-1 infection
16
Medical Condition: Chronic Hepatitis C Infectio...
16
Medical Condition: HIV-1 infection
14
Medical Condition: HIV
14
Medical Condition: HIV-1 Infected Treatment Nai...
13
Study Type: Observational
12
Medical Condition: Chronic Hepatitis C MedDRA v...
12
Medical Condition: HIV infection MedDRA version...
12
Medical Condition: HIV-infected individuals
12
Medical Condition: Treatment of HIV-1 infections
10
Medical Condition: COVID-19
10
Medical Condition: HIV infection
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
233
2020-
682
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
861
Englisch
36
Spanisch
12
Unbestimmt
4
Französisch
2
Deutsch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...